Metropolis Healthcare launches nexgen genome-sequencing TB diagnostics

WORLD – Metropolis healthcare, an Indian multinational chain of diagnostic companies, has launched a next generation sequencing (NGS) platform that can rapidly identify drug resistance in TB patients and provide data on genotypic type level of up to 18 TB antibiotics. The launch will be the first of its kind in India for a diagnostic service provider and will have Metropolis work alongside HaystackAnalytics, a startup providing genomics-based diagnostic services for infectious diseases. Metropolis healthcare is targeting to launch its NGS technology in Sri Lanka, Mauritius, the UAE, Kenya, Zambia,…

Read More